Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida , Gainesville, Florida.
Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G82-G94. doi: 10.1152/ajpgi.00299.2018. Epub 2018 Nov 1.
The anion exchanger SAT-1 [sulfate anion transporter 1 (Slc26a1)] is considered an important regulator of oxalate and sulfate homeostasis, but the mechanistic basis of these critical roles remain undetermined. Previously, characterization of the SAT-1-knockout (KO) mouse suggested that the loss of SAT-1-mediated oxalate secretion by the intestine was responsible for the hyperoxaluria, hyperoxalemia, and calcium oxalate urolithiasis reportedly displayed by this model. To test this hypothesis, we compared the transepithelial fluxes of C-oxalate, , and Cl across isolated, short-circuited segments of the distal ileum, cecum, and distal colon from wild-type (WT) and SAT-1-KO mice. The absence of SAT-1 did not impact the transport of these anions by any part of the intestine examined. Additionally, SAT-1-KO mice were neither hyperoxaluric nor hyperoxalemic. Instead, 24-h urinary oxalate excretion was almost 50% lower than in WT mice. With no contribution from the intestine, we suggest that this may reflect the loss of SAT-1-mediated oxalate efflux from the liver. SAT-1-KO mice were, however, profoundly hyposulfatemic, even though there were no changes to intestinal sulfate handling, and the renal clearances of sulfate and creatinine indicated diminished rates of sulfate reabsorption by the proximal tubule. Aside from this distinct sulfate phenotype, we were unable to reproduce the hyperoxaluria, hyperoxalemia, and urolithiasis of the original SAT-1-KO model. In conclusion, oxalate and sulfate transport by the intestine were not dependent on SAT-1, and we found no evidence supporting the long-standing hypothesis that intestinal SAT-1 contributes to oxalate and sulfate homeostasis. NEW & NOTEWORTHY SAT-1 is a membrane-bound transport protein expressed in the intestine, liver, and kidney, where it is widely considered essential for the excretion of oxalate, a potentially toxic waste metabolite. Previously, calcium oxalate kidney stone formation by the SAT-1-knockout mouse generated the hypothesis that SAT-1 has a major role in oxalate excretion via the intestine. We definitively tested this proposal and found no evidence for SAT-1 as an intestinal anion transporter contributing to oxalate homeostasis.
阴离子交换器 SAT-1[硫酸盐阴离子转运蛋白 1 (Slc26a1)]被认为是调节草酸和硫酸盐内稳态的重要调节剂,但这些关键作用的机制基础仍未确定。先前,SAT-1 敲除 (KO) 小鼠的特征表明,肠道中 SAT-1 介导的草酸分泌丧失是导致该模型中报告的高草酸尿症、高草酸血症和草酸钙尿石形成的原因。为了验证这一假设,我们比较了野生型 (WT) 和 SAT-1-KO 小鼠的回肠、盲肠和结肠远端分离的短环段上皮细胞之间 C-草酸、[14C] 硫酸盐和 Cl-的跨上皮通量。SAT-1 的缺失并未影响任何肠段对这些阴离子的转运。此外,SAT-1-KO 小鼠既不高草酸尿症也不高草酸血症。相反,24 小时尿草酸排泄量比 WT 小鼠低近 50%。由于肠道没有贡献,我们认为这可能反映了 SAT-1 介导的肝脏草酸外排的丧失。然而,SAT-1-KO 小鼠严重低硫酸盐血症,尽管肠道硫酸盐处理没有变化,而且硫酸盐和肌酐的肾清除率表明近端肾小管的硫酸盐重吸收率降低。除了这种明显的硫酸盐表型外,我们无法复制原始 SAT-1-KO 模型的高草酸尿症、高草酸血症和尿石形成。总之,肠道的草酸和硫酸盐转运不依赖于 SAT-1,我们没有发现任何证据支持长期存在的假设,即肠道 SAT-1 有助于草酸和硫酸盐的内稳态。新的和值得注意的是,SAT-1 是一种在肠道、肝脏和肾脏中表达的膜结合转运蛋白,它被广泛认为是排泄草酸的必需物质,草酸是一种潜在的有毒代谢物。先前,SAT-1 敲除小鼠的钙草酸肾结石形成产生了 SAT-1 通过肠道在排泄草酸中起主要作用的假说。我们明确地测试了这一假设,没有发现 SAT-1 作为肠道阴离子转运体有助于草酸内稳态的证据。